Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
430 participants
OBSERVATIONAL
2021-08-10
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SiREX-Stent for the Treatment of SymptOmatic Lateral VEnous Sinus Stenosis
NCT06726928
A Post Market Study to Confirm the Safety and Performance of the Signia™ Stapling System.
NCT03515811
European Aortic Data Collection Project
NCT05896397
A Multi-center Post-Market Surveillance Registry
NCT00438919
CO2-Angiography-Study to Evaluate Diagnostic and Safety to Patients With Peripher Arterial Stenotic or Occlusive Disease.
NCT05590182
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thoracic Adult
Use of Signia SDR for the transection of pulmonary arteries and veins in adult patients.
N/A observational registry
N/A observational registry
Abdominal Adult
Use of Signia SDR for the transection of renal arteries and veins in adult patients.
N/A observational registry
N/A observational registry
Abdominal Pediatric
Use of Signia SDR for the transection of the appendiceal stump and mesoappendix (simple acute appendicitis) in pediatric patients.
N/A observational registry
N/A observational registry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
N/A observational registry
N/A observational registry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has, or is intended to receive or be treated with, an eligible Medtronic product
* Patient is consented within the enrollment window of the therapy received, as applicable
Exclusion Criteria
* Patient is excluded by local law
* Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the PSR results
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cedars Sinai Medical Center
Los Angeles, California, United States
Children's Hospital Colorado
Denver, Colorado, United States
The George Washington University Hospital
Washington D.C., District of Columbia, United States
Rush
Chicago, Illinois, United States
Cooper Health System
Camden, New Jersey, United States
NYU Langone Medical Center
New York, New York, United States
New York Presbyterian Hospital - Colombia University Medical Center
New York, New York, United States
UNC Chapel Hill
Chapel Hill, North Carolina, United States
Duke University Health Systems
Durham, North Carolina, United States
Cleveland Clinic
Cleveland, Ohio, United States
UPMC Falk Clinic
Pittsburgh, Pennsylvania, United States
University of Texas - San Antonio
San Antonio, Texas, United States
Virginia Cancer Specialists
Fairfax, Virginia, United States
Mary Washington Hopital
Fredericksburg, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Surgical PSR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.